Our technology

Our proprietary technology combines hyperspectral analysis with artificial intelligence to classify embryos based on their metabolic profiles. We harness intrinsic signals coming from key cellular compounds, such as NADH, FADH, retinol or Protoporphyrin IX to define the metabolic profile of the sample.
See article
Our technology introduces a novel approach to imaging, combining key technologies for enhanced performance. Starting with gentle multiphoton illumination in the infrared spectrum, we prioritise sample safety. Next, our use of light-sheet technology enables rapid imaging of the embryo, improving efficiency and minimizing sample handling time. Finally, hyperspectral analysis adds quantitative insights, allowing detailed examination of multiple metabolites and mitochondrial
segmentation to better assess the quality of embryos.

Benefits

  • Label-free non-invasive imaging technology, delivers colour-coded metabolic evaluation in minutes, providing a deeper understanding of embryo quality, to support your classification decisions.
  • Highly quantitative data provides greater objectivity in the assessment of embryos than morphology alone.
  • Single cell segmentation allows the detection of metabolic differences with higher cellular resolution, differentiating the trophectoderm from the inner cell mass.
  • Live mitochondrial imaging and segmentation is more easily visualized to determine quality than current imaging protocols allow.
  • Early detection of apoptotic cells and oxidative stress, facilitates the identification of poor-quality embryos.
  • Easy implementation in clinical workflow, helps streamline the efficiency of your embryo screening protocols.